N-Nitroso Nintedanib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Nintedanib is used to treat idiopathic pulmonary fibrosis. It helps prevent changes to the lung tissue. It is also used to treat people with a chronic (long-lasting) interstitial lung disease in which lung fibrosis continues to progress or becomes worse.N-Nitroso Nintedanib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nintedanib Impurity 1 CAS NO:NA Chemically represented as Methyl (Z)-3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-1-nitroso-2-oxoindoline-6-carboxylate . Synchemia is the leading manufacturing and exporter of N-Nitroso Nintedanib Impurity 1 .We supply N-Nitroso Nintedanib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141876 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141877 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141878 |
| CAS No | NA |
| Mol.F. | C30H36N6O4 |
| Mol.Wt. | 544.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141879 |
| CAS No | NA |
| Mol.F. | C21H16IN3O2 |
| Mol.Wt. | 469.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141880 |
| CAS No | NA |
| Mol.F. | C12H13N5O2 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141881 |
| CAS No | NA |
| Mol.F. | C24H28N4O3 |
| Mol.Wt. | 420.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141882 |
| CAS No | NA |
| Mol.F. | C12H23N3O4 |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141883 |
| CAS No | NA |
| Mol.F. | C11H21N3O4 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141884 |
| CAS No | NA |
| Mol.F. | C5H3N5O2 |
| Mol.Wt. | 165.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141885 |
| CAS No | NA |
| Mol.F. | C13H18N2O2 |
| Mol.Wt. | 234.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141886 |
| CAS No | NA |
| Mol.F. | C22H18N4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141887 |
| CAS No | NA |
| Mol.F. | C22H16N4O5 |
| Mol.Wt. | 416.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141888 |
| CAS No | NA |
| Mol.F. | C23H20N4O3 |
| Mol.Wt. | 400.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141889 |
| CAS No | NA |
| Mol.F. | C27H23N5O6 |
| Mol.Wt. | 513.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141890 |
| CAS No | NA |
| Mol.F. | C21H16N4O3 |
| Mol.Wt. | 372.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141891 |
| CAS No | NA |
| Mol.F. | C28H19N5O9 |
| Mol.Wt. | 569.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |